1. Home
  2. WVE vs MCBS Comparison

WVE vs MCBS Comparison

Compare WVE & MCBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVE
  • MCBS
  • Stock Information
  • Founded
  • WVE 2012
  • MCBS 2006
  • Country
  • WVE Singapore
  • MCBS United States
  • Employees
  • WVE N/A
  • MCBS N/A
  • Industry
  • WVE Biotechnology: Pharmaceutical Preparations
  • MCBS Major Banks
  • Sector
  • WVE Health Care
  • MCBS Finance
  • Exchange
  • WVE Nasdaq
  • MCBS Nasdaq
  • Market Cap
  • WVE 915.6M
  • MCBS 744.2M
  • IPO Year
  • WVE 2015
  • MCBS 2019
  • Fundamental
  • Price
  • WVE $8.29
  • MCBS $29.49
  • Analyst Decision
  • WVE Strong Buy
  • MCBS Hold
  • Analyst Count
  • WVE 17
  • MCBS 1
  • Target Price
  • WVE $19.94
  • MCBS $34.00
  • AVG Volume (30 Days)
  • WVE 2.2M
  • MCBS 31.7K
  • Earning Date
  • WVE 07-30-2025
  • MCBS 10-17-2025
  • Dividend Yield
  • WVE N/A
  • MCBS 3.12%
  • EPS Growth
  • WVE N/A
  • MCBS 20.64
  • EPS
  • WVE N/A
  • MCBS 2.57
  • Revenue
  • WVE $93,946,000.00
  • MCBS $145,158,000.00
  • Revenue This Year
  • WVE N/A
  • MCBS $18.90
  • Revenue Next Year
  • WVE $10.02
  • MCBS $30.18
  • P/E Ratio
  • WVE N/A
  • MCBS $11.47
  • Revenue Growth
  • WVE N/A
  • MCBS 14.81
  • 52 Week Low
  • WVE $5.04
  • MCBS $24.24
  • 52 Week High
  • WVE $16.74
  • MCBS $36.15
  • Technical
  • Relative Strength Index (RSI)
  • WVE 41.39
  • MCBS 53.52
  • Support Level
  • WVE $7.12
  • MCBS $29.05
  • Resistance Level
  • WVE $10.45
  • MCBS $30.15
  • Average True Range (ATR)
  • WVE 0.54
  • MCBS 0.58
  • MACD
  • WVE -0.24
  • MCBS 0.05
  • Stochastic Oscillator
  • WVE 33.82
  • MCBS 61.50

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About MCBS MetroCity Bankshares Inc.

MetroCity Bankshares Inc is a holding company of its subsidiary Metro City Bank. It provides commercial banking services such as consumer and commercial checking accounts, savings accounts, certificates of deposits, commercial and consumer loans, money transfers and a variety of other banking services. The banks generate revenue from interest income. Its customers include small business owners, professionals, consumers, and real estate developers.

Share on Social Networks: